Description
Human Bevacizumab Quantitative Detection ELISA Kit | RAS-T122| Gentaur Distribution US, UK & Europe
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Source: A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF) . Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Molecule: Bevacizumab.
Format: Solid.
Species: Human.
Application: The kit is developed for quantitative detection of Bevacizumab antibody in human serum.
Kit Component: This assay kit employs a standard sandwich-ELISA format, providing a rapid detection of Bevacizumab. The kit consists of Pre-coated Anti-Bevacizumab Antibody Microplate and Bevacizumab Standard and Biotin-Anti-Bevacizumab Antibody and Streptavidin-HRP and buffers.
Stability: 1. Unopened kit should be stored at 2℃-8℃ upon receiving. 2. Find the expiration date on the outside packaging and do not use reagents past their expiration date. 3. The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.
Storage Conditions: 2-8℃.
Shipping Conditions: RT
